Kidney Tests in Heart Failure: Which Formula Works Best?

What Was Studied and Why It Matters

When someone has heart failure, their kidneys are often affected too. Doctors use blood tests to estimate how well the kidneys are filtering — a measurement called the glomerular filtration rate, or eGFR. The problem is there are at least six different math formulas used to calculate eGFR, and no one was sure which one gave the most useful picture for heart failure patients specifically.

Researchers from the MECKI-RENAL study analyzed data from 6,933 patients with a type of heart failure called reduced ejection fraction (HFrEF) — where the heart muscle isn't pumping efficiently. Their goal was to find out whether the choice of kidney formula changed how well doctors could predict serious outcomes like cardiovascular death or the need for a heart transplant.

What the Researchers Found

The six formulas tested were: MDRD, modified MDRD, Cockcroft-Gault (standard and modified), CKD-EPI, and the newer EKFC formula. Here is what the data showed:

• All six formulas predicted 2-year survival with similar accuracy — none was dramatically better than another.
• For predicting cardiovascular death specifically, accuracy scores (called AUC values) clustered tightly between 0.668 and 0.677 — a narrow range, meaning no formula stood out.
• The percentage of patients identified as having severe kidney disease (eGFR below 30) varied slightly — from 3.2% with MDRD up to 4.5% with EKFC — a reminder that formula choice can shift how patients are categorized.
• When kidney estimates were plugged into the broader MECKI risk score — a tool combining exercise test data, heart measurements, and kidney numbers — the overall prediction accuracy rose to around 0.78–0.79, much stronger than kidney data alone.
• The CKD-EPI and EKFC formulas performed marginally best inside the MECKI score, though differences were small.

What This Means for Real Patients

If you or a loved one has heart failure, this study carries reassuring news: your care team does not need to stress over which kidney formula their lab uses. All six produce clinically useful information, and the MECKI risk tool remains reliable regardless of which formula feeds into it.

For people managing diabetes alongside heart failure — a very common combination — kidney monitoring is especially important, since high blood sugar can damage the kidneys over time. Regular eGFR testing, alongside consistent glucose monitoring with quality supplies from MDS Diabetes, gives your healthcare team the complete picture they need for safe medication and treatment decisions.

The study also reinforces that kidney function alone only tells part of the story. Combined scoring tools that include exercise capacity and heart measurements add significant predictive power — something worth discussing with your cardiologist or nephrologist.

Bottom Line

Six common kidney function formulas performed equally well for predicting heart failure outcomes in a nearly 7,000-patient study. Doctors can confidently use whichever formula their clinic already relies on. For patients with diabetes and heart failure, the key takeaway is straightforward: keep up with your kidney tests, monitor your blood sugar consistently, and ask your doctor whether a comprehensive risk score like MECKI applies to your care plan.